The world needs effective drugs to fight COVID-19, and Indian scientists are close to making a breakthrough with repurposed drugs.
Immunologist Satyajit Rath on why he changed career course, and whether we would have been safer in the wild.
Soumitra Dutta is a Professor of Management at Cornell University and the Chair of the Board of Directors for Global Business School Network.
When COVID-19 disrupted health tech start-up Niramai’s revenue model, the company innovated to secure a lifeline.
Two scientists, across continents, collaborated to bring the mRNA vaccine to India.
The Mynvax vaccine is particularly suited for Indian conditions: it is stable at high temperatures, which eliminates the need for a cold chain during…
© 2021 IIT MADRAS - All rights reserved
Powered by RAGE